Cargando…
The burden of comorbidities in pulmonary arterial hypertension
Patients with comorbidities are often excluded from clinical trials, limiting the evidence base for pulmonary arterial hypertension (PAH)-specific therapies. This review aims to discuss the effect of comorbidities on the diagnosis and management of PAH. The comorbidities discussed in this review (sy...
Autores principales: | Lang, Irene M, Palazzini, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915052/ https://www.ncbi.nlm.nih.gov/pubmed/31857797 http://dx.doi.org/10.1093/eurheartj/suz205 |
Ejemplares similares
-
GPs Meet Rare Lung Disorders Task Force factsheet: pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2015) -
Challenges in pulmonary hypertension: managing the unexpected
por: Olsson, Karen M., et al.
Publicado: (2015) -
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses
por: Galiè, Nazzareno, et al.
Publicado: (2010) -
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2009) -
Pulmonary hypertension due to left heart disease
por: Vachiéry, Jean-Luc, et al.
Publicado: (2019)